1. Long-Term Remission With Low-Dose Rituximab in Myasthenia Gravis: A Retrospective Study. Issue 1 (September 2022) Authors: Castiglione, Juan I.; Rivero, Alberto D.; Barroso, Fabio; Brand, Patricio; Lautre, Andrea; Kohler, Alejandro A. Journal: Journal of clinical neuromuscular disease Issue: Volume 24:Issue 1(2022) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗